- Title
- International comparison of cosmetic outcomes of breast conserving surgery and radiation therapy for women with ductal carcinoma in situ of the breast
- Creator
- Olivotto, Ivo A.; Link, Emma; Phillips, Claire; Whelan, Timothy J.; Bryant, Guy; Kunkler, Ian H.; Westenberg, A. Helen; Purohit, Kash; Ahern, Verity; Graham, Peter H.; Akra, Mohamed; McArdle, Orla; Ludbrook, Joanna J.; Harvey, Jennifer A.; Maduro, John H.; Kirkove, Carine; Gruber, Guenther; Martin, Joseph D.; Campbell, Ian D.; Delaney, Geoff P.; Chua, Boon H.
- Relation
- Radiotherapy & Oncology Vol. 142, p. 180-185
- Publisher Link
- http://dx.doi.org/10.1016/j.radonc.2019.07.024
- Publisher
- Elsevier
- Resource Type
- journal article
- Date
- 2020
- Description
- Purpose: To assess the cosmetic impact of breast conserving surgery (BCS), whole breast irradiation (WBI) fractionation and tumour bed boost (TBB) use in a phase III trial for women with ductal carcinoma in situ (DCIS) of the breast. Materials and methods: Baseline and 3-year cosmesis were assessed using the European Organization for Research and Treatment of Cancer (EORTC) Cosmetic Rating System and digital images in a randomised trial of non-low risk DCIS treated with postoperative WBI +/− TBB. Baseline cosmesis was assessed for four geographic clusters of treating centres. Cosmetic failure was a global score of fair or poor. Cosmetic deterioration was a score change from excellent or good at baseline to fair or poor at three years. Odds ratios for cosmetic deterioration by WBI dose-fractionation and TBB use were calculated for both scoring systems. Results: 1608 women were enrolled from 11 countries between 2007 and 2014. 85–90% had excellent or good baseline cosmesis independent of geography or assessment method. TBB (16 Gy in 8 fractions) was associated with a >2-fold risk of cosmetic deterioration (p < 0.001). Hypofractionated WBI (42.5 Gy in 16 fractions) achieved statistically similar 3-year cosmesis compared to conventional WBI (50 Gy in 25 fractions) (p ≥ 0.18). The adverse impact of a TBB was not significantly associated with WBI fractionation (interaction p ≥ 0.30). Conclusions: Cosmetic failure from BCS was similar across international jurisdictions. A TBB of 16 Gy increased the rate of cosmetic deterioration. Hypofractionated WBI achieved similar 3-year cosmesis as conventional WBI in women treated with BCS for DCIS.
- Subject
- breast cancer; radiotherapy; cosmetic outcomes; fractionation; boost; breast conservation; SDG 3; Sustainable Development Goals
- Identifier
- http://hdl.handle.net/1959.13/1436818
- Identifier
- uon:40147
- Identifier
- ISSN:0167-8140
- Language
- eng
- Reviewed
- Hits: 5370
- Visitors: 5354
- Downloads: 0
Collections
Goal 3: Good Health and Well-Being
| Thumbnail | File | Description | Size | Format |
|---|